177575-17-6 Usage
Uses
Used in Pharmaceutical Industry:
AG2034 is used as a therapeutic agent for the treatment of psychiatric and neurological disorders. Its application is based on its ability to inhibit the enzyme monoamine oxidase A (MAO-A), which can lead to increased levels of neurotransmitters such as serotonin, dopamine, and norepinephrine in the brain.
Used in Research Applications:
AG2034 is used as a research tool in preclinical studies to investigate the potential therapeutic effects of inhibiting MAO-A in conditions such as depression, anxiety, and neurodegenerative diseases. Its role in these studies is to provide insights into the mechanisms by which modulation of neurotransmitter levels can influence the progression and treatment of these disorders.
Used in Drug Development:
AG2034 is used as a lead compound in the development of new drugs targeting the monoamine oxidase A (MAO-A) enzyme. Its potent and selective inhibition of MAO-A makes it a promising candidate for further optimization and development into a potential therapeutic agent for the treatment of psychiatric and neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 177575-17-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,5,7 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 177575-17:
(8*1)+(7*7)+(6*7)+(5*5)+(4*7)+(3*5)+(2*1)+(1*7)=176
176 % 10 = 6
So 177575-17-6 is a valid CAS Registry Number.
InChI:InChI=1/C18H21N5O6S2/c19-18-22-14-13(16(27)23-18)31-9(7-20-14)2-1-8-3-5-11(30-8)15(26)21-10(17(28)29)4-6-12(24)25/h3,5,9-10H,1-2,4,6-7H2,(H,21,26)(H,24,25)(H,28,29)(H4,19,20,22,23,27)/t9-,10-/m0/s1
